Skip to Main content Skip to Navigation
Journal articles

The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo.

Abstract : Enterovirus 71 (EV71) causes severe central nervous system infections, leading to cardiopulmonary complications and death in young children. There is an urgent unmet medical need for new pharmaceutical agents to control EV71 infections. Using a multidisciplinary approach, we found that the approved pediatric antiparasitic drug suramin blocked EV71 infectivity by a novel mechanism of action that involves binding of the naphtalentrisulonic acid group of suramin to the viral capsid. Moreover, we demonstrate that when suramin is used in vivo at doses equivalent to or lower than the highest dose already used in humans, it significantly decreased mortality in mice challenged with a lethal dose of EV71 and peak viral load in adult rhesus monkeys. Thus, suramin inhibits EV71 infection by neutralizing virus particles prior to cell attachment. Consequently, these findings identify suramin as a clinical candidate for further development as a therapeutic or prophylactic treatment for severe EV71 infection.
Document type :
Journal articles
Complete list of metadatas

Cited literature [38 references]  Display  Hide  Download

https://hal-pasteur.archives-ouvertes.fr/pasteur-01179295
Contributor : Cécile Pham <>
Submitted on : Wednesday, July 22, 2015 - 10:54:58 AM
Last modification on : Thursday, May 28, 2020 - 11:58:05 PM
Long-term archiving on: : Friday, October 23, 2015 - 10:32:55 AM

File

emi201460a.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Peijun Ren, Gang Zou, Benjamin Bailly, Shanshan Xu, Mei Zeng, et al.. The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo.. Emerging microbes & infections, Earliest : Springer-Nature ; Latest : Taylor & Francis, 2014, 3 (9), pp.e62. ⟨10.1038/emi.2014.60⟩. ⟨pasteur-01179295⟩

Share

Metrics

Record views

1022

Files downloads

944